Figure 8. HTM express EDA+ and EDB+ fibronectin isoforms both of which are susceptible to disruption by FUD.

Cells were grown to confluence at which time treatment with vehicle or 500 nM DEX in the presence of absence of 2 µM FUD was initiated. Cells were treated for 7 days prior to fixation and labeling with fibronectin polyclonal antisera (FN pAb), mAb IST-9 against EDA+ fibronectin or mAb BC-1 against EDB+ fibronectin. Scale bars = 50 µm.